Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Shire plc | dp33986_8k.htm |
| EX-99.2 - EXHIBIT 99.2 - Shire plc | dp33986_ex9902.htm |
| EX-99.1 - EXHIBIT 99.1 - Shire plc | dp33986_ex9901.htm |
Exhibit 99.03
|
Press Release
|
 |
|
www.shire.com
|
Transaction in Own Shares
November 2, 2012 – Shire plc (the “Company”) (LSE: SHP, NASDAQ: SHPG), announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on April 24, 2012 it purchased 105,399 of its ordinary shares of 5 pence each on November 2, 2012. The highest and lowest price paid for these shares was 1780.00 pence per share and 1759.00 pence per share respectively.
The purchased shares will be held as treasury shares. Following the above purchase, the Company holds 576,400 shares as treasury shares, and has 561,961,958 shares in issue (excluding treasury shares).
For further information please contact:
|
Investor Relations
|
||
|
Eric Rojas
|
erojas@shire.com
|
+1 781 482 0999
|
|
Sarah Elton-Farr
|
seltonfarr@shire.com
|
+44 1256 894157
|
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Through our deep understanding of patients’ needs, we develop and provide healthcare in the areas of:
|
|
·
|
Behavioral Health and Gastro Intestinal conditions
|
|
|
·
|
Rare Diseases
|
|
|
·
|
Regenerative Medicine
|
as well as other symptomatic conditions treated by specialist physicians.
We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders.